Multaq (dronedarone) is a prescription drug used to reduce the risk of hospitalization in certain adults with atrial fibrillation (AFib). Multaq can cause side effects that range from mild to serious.

Multaq (dronedarone) is a prescription drug used to help reduce the risk of a hospital stay for adults with a history of atrial fibrillation (AFib). The drug comes as an oral tablet that’s usually ...

Multaq (dronedarone) is a brand-name oral tablet that’s prescribed to reduce a certain risk associated with atrial fibrillation. Multaq has interactions with some other drugs and certain supplements.

The PALLAS trial of dronedarone (Multaq) for permanent AF has been stopped early, according to a press release (below) issued by Sanofi. PALLAS (Permanent Atrial fibriLLAtion outcome Study using ...

A trial of the drug Multaq, used to treat abnormal heart rhythm, has been halted over concerns of other heart-related side effects, drug maker Sanofi announced Thursday. Multaq, also known as ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended new restriction on dronedarone (Multaq), Sanofi's embattled and controversial antiarrhythmic drug.

Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalizationin Patients With Atrial Fibrillation or Atrial Flutter. PARIS, July 2 /PRNewswire/ -- - U.S Commercial Launch Planned for the ...

- Benefit-risk of Multaq remains unchanged in non-permanent AF patients - Paris, France - July 7, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the company has discontinued the ...

Before Sanofi-Aventis launched its heart drug Multaq, some analysts estimated revenues would top €3 billion. But 10 weeks into the launch, Multaq looks like a much more modest affair, according to a ...

PARIS, Nov 16 (Reuters) - Sanofi's irregular heart beat drug Multaq will no longer be reimbursed by the French health system from December, in a further setback to a medicine once seen as a ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Dronedarone, a highly touted drug targeted at atrial fibrillation and ...